Treffer 1 - 2 von 2 für Suche 'Kaesshaefer, Steve', Suchdauer: 0,28s Treffer weiter einschränken
  1. 1
    CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM)

    CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM) von Iwamoto, Fabio, Gondi, Vinai, Butowski, Nicholas, Falchook, Gerald, Williams, Anja, Peters, Katherine B, Evans, Jeff, Lakhani, Nehal, McKean, Meredith, Symeonides, Stefan, Ellingson, Benjamin, Rotolo, Jim, Capiaux, Gina, Wiegert, Erol, Michel, Rob, Kaesshaefer, Steve, Bexon, Alice


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Abstract LB236: ST101, a peptide antagonist of novel I/O target CEBPβ,reprograms MDSCs and promotes an immunoactive tumor microenvironment

    Abstract LB236: ST101, a peptide antagonist of novel I/O target CEBPβ,reprograms MDSCs and promotes an immunoactive tumor microenvironment von Scuoppo, Claudio, Ramirez, Rick, Leong, Siok, Ghamsari, Lila, Capiaux, Gina, Michel, Rob, Kaesshaefer, Steve, Merutka, Gene, Kappel, Barry, Vainstein-Haras, Abi, Bexon, Alice, Rotolo, Jim

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: